Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026
Manufacturing and Production AI, Made Smarter

A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Maninder Kapoor Puri as …

BioPhorum acquires PharmaX Solutions

May 5, 2026
Manufacturing and Production BioPhorum, PharmaX Solutions

BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and …

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026
Research and Development Syngene International

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), has announced the appointment of Abhijit Zutshi as Chief …

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026
Peptide therapies, peptide

Japanese pharmaceutical companies are increasingly engaging contract development and manufacturing organisations (CDMOs) earlier in the drug development process, as the …

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026
Research and Development fatty liver disease, phospholipid therapy

A randomised clinical trial has reported that treatment with essential phospholipids (Essentiale) may reduce liver fat and improve symptoms in …

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026
Neurology, mental health

The US Food and Drug Administration (FDA) has announced a series of measures aimed at supporting the development of psychedelic-based …

New web series explores path from ophthalmic research to patient access

April 28, 2026
Research and Development Opthalmology

A new YouTube web series has been launched to examine how ophthalmic innovations progress from early research through to approved …

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026
Research and Development The European Medicines Agency (EMA), plozasiran

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Redemplo (plozasiran) to treat adults with familial chylomicronaemia …

Study explores speech as marker in rare neurodegenerative disease

April 27, 2026
Research and Development SynaptixBio, neurodegenerative disease

SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …

Ofichem brings all brands under single trading name

April 23, 2026
Ofichem

Ofichem has brought all its brands under its trading name to provide its customers a single integrated offering. The company …

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026
Carvolix

Carvolix (formerly Affluent Medical) has announced it is strengthening its Board of Directors, advisory board and governance structure. As part …

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026
University of Huddersfield’s NHIC

Dr Zubir Ahmed MP, the Under-Secretary of State for Health Innovation and Safety, recently visited the newly opened Emily Siddon …

Incyclix Bio announces new additions to the Board

April 22, 2026
Incyclix Bio

Incyclix Bio has announced that it has raised $5m in additional funds for its Series B financing from new investor …

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026
Remedy Plan Therapeutics

Remedy Plan Therapeutics has appointed Jotin Marango as Chief Financial and Business Officer (CFO & CBO). “Joti brings a strong …

Xilio Therapeutics appoints Cheryl R Blanchard to Board

April 20, 2026
Xilio Therapeutics

Xilio Therapeutics has announced the appointment of Cheryl R Blanchard to the company’s board of directors. The company also announced …

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026
Research and Development RWS, kayentis

Kayentis and RWS have announced a partnership aimed at improving confidence in clinical trial data for neuroscience and other complex …

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026
Research and Development

The Medicines and Healthcare products Regulatory Agency (MHRA) has secured new funding to expand its AI Airlock programme, aimed at …

Ardena opens new US bioanalytical laboratory

April 15, 2026
Business Services

Ardena has announced that its new GLP bioanalytical laboratory in Somerset, New Jersey in the US is operational and supporting …

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026
Research and Development Gesynta Pharma, endometriosis

Gesynta Pharma has dosed the first patient in its phase 2 clinical proof-of-concept trial of vipoglanstat. The trial, NOVA, is …

The Gateway to Local Adoption Series

Latest content